Abstract:Integration of the viral DNA into host chromosomes was found in most of the hepatitis B virus (HBV)-related hepatocellular carcinomas (HCCs). Here we devised a massive anchored parallel sequencing (MAPS) method using next-generation sequencing to isolate and sequence HBV integrants. Applying MAPS to 40 pairs of HBV-related HCC tissues (cancer and adjacent tissues), we identified 296 HBV integration events corresponding to 286 unique integration sites (UISs) with precise HBV-Human DNA junctions. HBV integration favored chromosome 17 and preferentially integrated into human transcript units. HBV targeted genes were enriched in GO terms: cAMP metabolic processes, T cell differentiation and activation, TGF beta receptor pathway, ncRNA catabolic process, and dsRNA fragmentation and cellular response to dsRNA. The HBV targeted genes include 7 genes (PTPRJ, CNTN6, IL12B, MYOM1, FNDC3B, LRFN2, FN1) containing IPR003961 (Fibronectin, type III domain), 7 genes (NRG3, MASP2, NELL1, LRP1B, ADAM21, NRXN1, FN1) containing IPR013032 (EGF-like region, conserved site), and three genes (PDE7A, PDE4B, PDE11A) containing IPR002073 (3', 5'-cyclic-nucleotide phosphodiesterase). Enriched pathways include hsa04512 (ECM-receptor interaction), hsa04510 (Focal adhesion), and hsa04012 (ErbB signaling pathway). Fewer integration events were found in cancers compared to cancer-adjacent tissues, suggesting a clonal expansion model in HCC development. Finally, we identified 8 genes that were recurrent target genes by HBV integration including fibronectin 1 (FN1) and telomerase reverse transcriptase (TERT1), two known recurrent target genes, and additional novel target genes such as SMAD family member 5 (SMAD5), phosphatase and actin regulator 4 (PHACTR4), and RNA binding protein fox-1 homolog (C. elegans) 1 (RBFOX1). Integrating analysis with recently published whole-genome sequencing analysis, we identified 14 additional recurrent HBV target genes, greatly expanding the HBV recurrent target list. This global survey of HBV integration events, together with recently published whole-genome sequencing analyses, furthered our understanding of the HBV-related HCC.

Noninvasive chimeric DNA profiling identifies tumor-originated HBV integrants contributing to viral antigen expression in liver cancer

Characterization of Hepatitis B Virus Integrations Identified in Hepatocellular Carcinoma Genomes

Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma

HBV DNA Integration into Telomerase or MLL4 Genes and TERT Promoter Point Mutation as Three Independent Signatures in Subgrouping HBV-Related HCC with Distinct Features

Characterization of HBV integration patterns and timing in liver cancer and HBV-infected livers

Temporal and structural patterns of hepatitis B virus integrations in hepatocellular carcinoma

Identification of HBV-MLL4 Integration and Its Molecular Basis in Chinese Hepatocellular Carcinoma.

Distinct Hepatitis B Virus Integration Patterns in Hepatocellular Carcinoma and Adjacent Normal Liver Tissue

Viral integration drives multifocal HCC during the occult HBV infection

Characterization Of Hepatitis B Virus Dna Integration Patterns In Intrahepatic Cholangiocarcinoma

The Landscape of Cell-Free HBV Integrations and Mutations in Cirrhosis and Hepatocellular Carcinoma Patients

The Effects of Hepatitis B Virus Integration into the Genomes of Hepatocellular Carcinoma Patients

Recurrent Targeted Genes of Hepatitis B Virus in the Liver Cancer Genomes Identified by a Next-Generation Sequencing–Based Approach

HBV Rewires Liver Cancer Signaling by Altering PP2A Complexes

Genomic and Transcriptome Profiling Identified Both Human and HBV Genetic Variations and Their Interactions in Chinese Hepatocellular Carcinoma

Three-dimensional and single-cell sequencing of liver cancer reveals comprehensive host-virus interactions in HBV infection

Identification of Characteristic TRB V Usage in HBV-associated HCC by Using Differential Expression Profiling Analysis.

Deep Whole-Genome Analysis of 494 Hepatocellular Carcinomas

Whole-Exome Sequencing-Based Mutational Profiling of Hepatitis B Virus-Related Early-Stage Hepatocellular Carcinoma

Re-Evaluation Of The Carcinogenic Significance Of Hepatitis B Virus Integration In Hepatocarcinogenesis

Multiomics analyses reveal pathological mechanisms of HBV infection and integration in liver cancer